These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 271755)

  • 1. Increased synthesis of striatal dopamine by N,N-dimethyltryptamine.
    Smith TL
    Life Sci; 1977 Dec; 21(11):1597-601. PubMed ID: 271755
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

  • 3. N'N-dimethyltryptamine lowers rat brain acetylcholine and dopamine.
    Haubrich DR; Wang PF
    Brain Res; 1977 Aug; 131(1):158-61. PubMed ID: 267501
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.
    Andén NE; Atack CV; Svensson TH
    J Neural Transm; 1973; 34(2):93-100. PubMed ID: 4722575
    [No Abstract]   [Full Text] [Related]  

  • 5. Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain.
    Leonard BE
    Psychopharmacologia; 1974 Apr; 36(3):221-36. PubMed ID: 4846327
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines.
    Horn AS; Baumgarten HG; Schlosserberger HG
    J Neurochem; 1973 Jul; 21(1):233-6. PubMed ID: 4720899
    [No Abstract]   [Full Text] [Related]  

  • 7. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamine.
    Saner A; Pieri L; Moran J; Da Prada M; Pletscher A
    Brain Res; 1974 Aug; 76(1):109-17. PubMed ID: 4844098
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 10. Lateral hypothalamic lesions and striatal dopamine levels.
    Glick SD; Greenstein S; Waters DH
    Life Sci; 1974 Feb; 14(4):747-50. PubMed ID: 4823629
    [No Abstract]   [Full Text] [Related]  

  • 11. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1986; 43(5):590-6. PubMed ID: 3528901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of trace amines with dopamine in rat striatum.
    Baker GB; Yasensky DL
    Prog Neuropsychopharmacol; 1981; 5(5-6):577-80. PubMed ID: 7339651
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons.
    Groppetti A; Algeri S; Cattabeni F; Di Giulio AM; Galli CL; Ponzio F; Spano PF
    J Neurochem; 1977 Jan; 28(1):193-7. PubMed ID: 833592
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum.
    Ennis C; Kemp JD; Cox B
    J Neurochem; 1981 Apr; 36(4):1515-20. PubMed ID: 7264648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gamma-hydroxybutyrate on mouse striatal tyramine, dopamine and homovanillic acid.
    Juorio AV
    Br J Pharmacol; 1982 Mar; 75(3):447-50. PubMed ID: 7066598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of estradiol and progesterone on the concentration of striatal dopamine and tyramine in ovariectomized mice.
    Yeung SC; Juorio AV
    Gen Pharmacol; 1985; 16(5):517-9. PubMed ID: 4054576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of tryptamine analogs with 5-hydroxytryptamine and dopamine in rat striatum in vitro.
    Baker GB; Hiob LE; Martin IL; Mitchell PR; Dewhurst WG
    Proc West Pharmacol Soc; 1980; 23():167-70. PubMed ID: 7403121
    [No Abstract]   [Full Text] [Related]  

  • 19. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
    Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
    Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings].
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1978 Jun; 63(2):380P. PubMed ID: 276408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.